Yukon Wealth Management Inc. Purchases 76 Shares of Procter & Gamble Company (The) $PG

Yukon Wealth Management Inc. boosted its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,662 shares of the company’s stock after acquiring an additional 76 shares during the period. Yukon Wealth Management Inc.’s holdings in Procter & Gamble were worth $583,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC boosted its stake in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $1,954,941,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its stake in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG opened at $152.62 on Monday. The company has a market capitalization of $357.21 billion, a P/E ratio of 22.28, a price-to-earnings-growth ratio of 4.05 and a beta of 0.36. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.45. The firm has a 50 day moving average of $154.66 and a 200 day moving average of $158.38. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.51%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Insider Activity at Procter & Gamble

In related news, CEO Jennifer L. Davis sold 3,227 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 over the last ninety days. Corporate insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Raymond James Financial cut their target price on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday. BNP Paribas Exane dropped their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Finally, Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $171.68.

View Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.